Skip to main content

Bivalirudin Injection Shortage

Last Updated: June 19, 2020
Status: Resolved

Reason for the Shortage
    • Accord has bivalirudin available.
    • Apotex has discontinued bivalirudin.
    • AuroMedics did not provide a reason for the shortage.
    • Baxter has 250 mg/50 mL bivalirudin premixed bags available. The company is not actively producing the 500 mg/100 mL bags due to low demand.
    • Dr. Reddy's did not provide a reason for the shortage.
    • Fresenius Kabi has bivalirudin available.
    • Pfizer has bivalirudin available.
    • Sandoz has bivalirudin available.
Available Products
    • Angiomax lyophilized powder for injection, Sandoz, 250 mg, vial, 10 count, NDC 65293-0001-01
    • Bivalirudin lyophilized powder for injection, AuroMedics, 250 mg, vial, 10 count, NDC 55150-0210-10
    • Bivalirudin lyophilized powder for injection, Dr. Reddy's, 250 mg, vial, 10 count, NDC 55111-0652-37
    • Bivalirudin lyophilized powder for injection, Fresenius Kabi, 250 mg, vial, 10 count, NDC 63323-0562-10
    • Bivalirudin lyophilized powder for injection, Pfizer, 250 mg, ADD-Vantage vial, 10 count, NDC 00409-8300-15
    • Bivalirudin lyophilized powder for injection, Pfizer, 250 mg, vial, 10 count, NDC 00409-8300-10
    • Bivalirudin lyophilized powder for injection, Sandoz, 250 mg, vial, 10 count, NDC 00781-3158-95
    • Bivalirudin injection, Baxter, 250 mg/50 mL, premixed bag, 24 count, NDC 00338-9572-24

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated June 19, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 4, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer